US 9358287
Method of treating stress hyperglycemia with human antibodies to the glucagon receptor
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9358287 (Method of treating stress hyperglycemia with human antibodies to the glucagon receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K38/28, A61K39/39541